Literature DB >> 6469755

Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.

C J Koch, C C Stobbe, K A Baer.   

Abstract

Under conditions of extreme hypoxia, metabolic products of the metabolism of misonidazole bind to cellular molecules at a rate which is linear with time and proportional to the square root of misonidazole concentration. Very small amounts of oxygen reduce the overall rate of binding and cause a change in the dependence on misonidazole concentration from square root (half order) to linear (first order). Because of the known electron affinity of misonidazole, a model is presented whereby the nitro-group is reduced to a radical in a first order reaction. This radical binds to cellular molecules in a slow first order reaction and either disproportionates or dimerizes in a fast second order reaction. Based on the overall effect of oxygen on the kinetics of the rate of binding, the radical is tentatively assumed to be the 3 electron reduction product.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469755     DOI: 10.1016/0360-3016(84)90342-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.

Authors:  Diane Marotta; Jayashree Karar; W Timothy Jenkins; Monika Kumanova; Kevin W Jenkins; John W Tobias; Donald Baldwin; Artemis Hatzigeorgiou; Panagiotis Alexiou; Sydney M Evans; Rodolfo Alarcon; Amit Maity; Cameron Koch; Constantinos Koumenis
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

Review 2.  Optimizing hypoxia detection and treatment strategies.

Authors:  Cameron J Koch; Sydney M Evans
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

3.  The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.

Authors:  E O Aboagye; R J Maxwell; M R Horsman; A D Lewis; P Workman; M Tracy; J R Griffiths
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?

Authors:  Makiko Suehiro; Paul Burgman; Sean Carlin; Sean Burke; Guangbin Yang; Ouathek Ouerfelli; Christoph Oehler-Janne; Joseph O'Donoghue; Clifton Ling; John Humm
Journal:  Nucl Med Biol       Date:  2009-05-07       Impact factor: 2.408

5.  Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.

Authors:  J A Raleigh; A J Franko; C J Koch; J L Born
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

6.  Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.

Authors:  M B Parliament; L I Wiebe; A J Franko
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

7.  Modulation of the hypoxic toxicity and binding of misonidazole by glucose.

Authors:  L L Ling; R M Sutherland
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

8.  Dependence of misonidazole binding on factors associated with hypoxic metabolism.

Authors:  L L Ling; R M Sutherland
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

9.  Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.

Authors:  C J Koch; S M Evans; E M Lord
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

10.  Oxygen dependence for chemosensitization by misonidazole.

Authors:  L Roizin-Towle; E J Hall; J P Pirro
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.